These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1601 related items for PubMed ID: 3923027

  • 1. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 2. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y.
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [Abstract] [Full Text] [Related]

  • 3. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [Abstract] [Full Text] [Related]

  • 4. The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy.
    Pescovitz OH, Comite F, Hench K, Barnes K, McNemar A, Foster C, Kenigsberg D, Loriaux DL, Cutler GB.
    J Pediatr; 1986 Jan; 108(1):47-54. PubMed ID: 3080571
    [Abstract] [Full Text] [Related]

  • 5. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA, Mansfield MJ, Wierman ME, Rudlin CR, Bode HH, Crigler JF, Crawford JD, Crowley WF.
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [Abstract] [Full Text] [Related]

  • 6. Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty.
    Comite F, Pescovitz OH, Rieth KG, Dwyer AJ, Hench K, McNemar A, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):888-92. PubMed ID: 6434587
    [Abstract] [Full Text] [Related]

  • 7. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [Abstract] [Full Text] [Related]

  • 8. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 9. Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty.
    Swaenepoel C, Chaussain JL, Roger M.
    Horm Res; 1991 Jan; 36(3-4):126-30. PubMed ID: 1840142
    [Abstract] [Full Text] [Related]

  • 10. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
    Mansfield MJ, Rudlin CR, Crigler JF, Karol KA, Crawford JD, Boepple PA, Crowley WF.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
    [Abstract] [Full Text] [Related]

  • 11. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
    Comite F, Cassorla F, Barnes KM, Hench KD, Dwyer A, Skerda MC, Loriaux DL, Cutler GB, Pescovitz OH.
    JAMA; 1986 May 16; 255(19):2613-6. PubMed ID: 3084811
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
    Crowley WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1981 Feb 16; 52(2):370-2. PubMed ID: 6780592
    [Abstract] [Full Text] [Related]

  • 13. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH, Barnes KM, Cutler GB.
    J Clin Endocrinol Metab; 1991 Jan 16; 72(1):60-4. PubMed ID: 1898743
    [Abstract] [Full Text] [Related]

  • 14. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
    Manasco PK, Pescovitz OH, Feuillan PP, Hench KD, Barnes KM, Jones J, Hill SC, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1988 Aug 16; 67(2):368-72. PubMed ID: 3292562
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 16. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH, Comite F, Cassorla F, Dwyer AJ, Poth MA, Sperling MA, Hench K, McNemar A, Skerda M, Loriaux DL.
    J Clin Endocrinol Metab; 1984 May 24; 58(5):857-61. PubMed ID: 6368580
    [Abstract] [Full Text] [Related]

  • 17. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec 24; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 18. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    Laue L, Jones J, Barnes KM, Cutler GB.
    J Clin Endocrinol Metab; 1993 Jan 24; 76(1):151-5. PubMed ID: 8421081
    [Abstract] [Full Text] [Related]

  • 19. Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls.
    Hall DA, Crowley WF, Wierman ME, Simeone JF, McCarthy KA.
    J Clin Ultrasound; 1986 Jun 24; 14(5):331-8. PubMed ID: 3088048
    [Abstract] [Full Text] [Related]

  • 20. Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.
    Laue L, Comite F, Hench K, Loriaux DL, Cutler GB, Pescovitz OH.
    Am J Dis Child; 1985 Nov 24; 139(11):1097-100. PubMed ID: 3933329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.